Cosimo Sperti.pdf

He focused his scientific interests in experimental pancreatic carcinogenesis, diagnosis, treatment and follow-up of pancreatic diseases, both benign and malignant. He is Author or coauthor of several articles published in academic journals or book’s chapters. He is member of Editorial board of World Journal of Gastroenterology, World Journal of Gastrointestinal Oncology, World Journal of Surgery, Scientifica,  Journal of Tumor,  International Journal of Endocrine Oncology, International Journal of Case Reports in Medicine (IBIMA Publishing), Austin Journal of Gastroenterology, Archives of Clinical gastroenterology, Journal of Clinical Gastroenterology and Hepatology, Journal of Endocrine Disorders, Surgery Research and Practice, and reviewed for over 40 academic journals.

Member of Italian Association for the Study of the Pancreas (A.I.S.P.)
Member of the Italian Society of Surgery (SIC)
Member of the Italian Society of Surgical Oncology (SICO)
Member of the International Society of Surgery  (ISS)
Member of the European Society of Surgical Oncology (ESSO).
Member  of the European Pancreatic Club (EPC)
Member of the International Association of Pancreatology (IAP)

1. SPERTI C, Pasquali C., Ferronato A., Pedrazzoli S. Median pancreatectomy for tumors of the neck and body of the pancreas. J Am Coll Surg 190: 711-716,. 2000.

2. SPERTI C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-Fluordeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 234: 675-80, 2001

3. SPERTI C, Pasquali C, Liessi G, Pinciroli L,  Decet D, Pedrazzoli S. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol 83: 161-166, 2003

4. SPERTI C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma J Gastrointest Surg 7: 953-60, 2003

5.SPERTI C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2007; 246: 932-939

6. Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptolemos J, Milanetto AC, Sperti C, et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut.;65(2):305-12, 2016

7. Sperti C, Gruppo M, Blandamura S, Valmasoni M, Pozza G, Passuello N, Beltrame V, Moletta L. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.World J  Gastroenterol. 2017 Jun 28;23(24):4399-4406.

8. Marco Segatto, Raffaella Fittipaldi, Fabrizio Pin, Roberta Sartori, Kyung Dae Ko, Hossein Zare, Claudio Fenizia, Gianpietro Zanchettin, Elisa Sefora Pierobon, Shinji Hatakeyama, Cosimo Sperti, Stefano Merigliano, Marco Sandri,  Panagis Filippakopoulos, Paola Costelli, Vittorio Sartorelli, Giuseppina Caretti. Epigenetic Targeting of Bromodomain Protein BRD4 Counteracts Cancer Cachexia and Prolongs Survival. Nature Communications 2017; 8(1):1707

9. Pastorelli D, Fabricio ASC, Giovanis P, D’Ippolito S, Fiduccia P, Soldà C, Buda A, SPERTI C, Bardini R, Da Dalt G, Rainato G, Gion M, Ursini F. Phytosome complex of Curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacological Research 2018; 132: 72-79.

10. Moletta L, Bissoli S, Fantin A, Passuello N, Valmasoni M, SPERTI C. PET/CT Incidental Detection of Second Tumor in Patients Investigated for Pancreatic Neoplasms. BMC Cancer 2018; 18: 531; DOI: 10.1186/s12885-018-4469-4